financetom
Business
financetom
/
Business
/
Merck's bowel disease drug meets main goal in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's bowel disease drug meets main goal in late-stage trial
Jun 22, 2026 4:34 AM

June 22 (Reuters) - Merck ( MRK ) said on Monday its drug

met the main goal in a late-stage trial testing it in patients

with a type of inflammatory bowel disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved